PEP-Therapy
Innovative peptides
as targeted therapies for oncology
LATEST NEWS
April 25th, 2024
PEP-Therapy and Institut Curie announce first patients dosed in Phase Ib clinical trial evaluating PEP-010 in ovarian and pancreatic cancers.
+ READ MORE
October 5th, 2023
We are happy to announce that we will present the results from the Phase Ia on PEP-010 at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 11-15, Boston, MA. Come and visit our poster!
April 11th, 2023
We are happy to share updates on our PEP-010 program at the AACR Annual Meeting which will be held April 14-19 in Orlando, FL. Come and visit our poster!
+ READ MORE
